Physician profile
Melissa Jean Wright
NPI 1437855350
$1,003.91
in general payments reported to CMS, 2019-2025
14 companies · $548 in 2025
The $548 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $50.40 · 2024: $405 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,003.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $278.95 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Viiv Healthcare Company | $243.69 | 2025 | Apretude, Cabenuva, Dovato |
| Abbvie INC. | $94.37 | 2024-2025 | |
| Pfizer INC. | $78.99 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $65.92 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Gilead Sciences, INC. | $53.96 | 2025 | |
| Amgen INC. | $34.89 | 2025 | Otezla, Repatha |
| Merck Sharp & Dohme LLC | $30.52 | 2025 | Pifeltro |
| Exact Sciences Corporation | $28.68 | 2025 | The Cologuard Plus Collection Kit |
| Tolmar, INC. | $21.00 | 2024 | |
| Ironshore Pharmaceuticals INC. | $19.76 | 2024 | |
| Antares Pharma, INC. | $18.69 | 2025 | Xyosted |
| Lilly USA, LLC | $17.36 | 2025 | Mounjaro, Zepbound |
| Halozyme INC | $17.13 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.